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Abstract
Background: Epithelioid sarcoma is a rare, high-grade malignant tumor of the soft tissue. The incidence of local
recurrence, regional lymph node involvement, and distant metastases is high. Epithelioid sarcoma is most often
seen in adolescents and young adults. In the early stage before the development of full clinical features, epithelioid
sarcoma is often misdiagnosed as a benign disease such as granuloma.
Case presentation: We report a case of a 74-year-old Japanese woman whose epithelioid sarcoma was initially
misdiagnosed as fungal infection. Rebiopsy revealed the proliferation of atypical polygonal or oval epithelioid cells
in the dermis and lymphocyte infiltration through the dermis. Immunohistochemically, the tumor cells were
positive for vimentin, cell adhesion molecule 5.2, epithelial membrane antigen, and E26-related gene. The nuclear
expression of integrase interactor 1 was lost in the tumor cells.
Conclusions: We encountered a rare case of epithelioid sarcoma and had difficulty in making the correct diagnosis.
We suggest that in patients whose lesions are resistant to conventional treatments, repeat biopsy and
immunohistochemical studies should be considered to rule out rare epithelioid sarcoma.
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Background
Epithelioid sarcoma (ES), first described by Enzinger in
1970 [1], is a rare sarcoma localized to deep or superficial
soft tissue. It is the most common soft tissue sarcoma of
the hand and wrist, followed by alveolar rhabdomyosar-
coma and synovial sarcoma. ES can develop at any age but
is rarely seen in children and the elderly. Because it is very
rare and appears to be a benign lesion in the early stage,
ES is often misdiagnosed as a benign disease such as
granuloma. We report a case of a patient with ES on the
hand and forearm with multiple satellite cutaneous
lesions.
Case presentation
A 74-year-old Japanese woman presented to our hospital
with multiple ulcerated nodules on the left hand and
forearm. The nodules had slowly increased in size and
number for 2 months. An examination revealed a 2-cm
ulcerated nodule on her left hand; she had multiple
satellite lesions on her left hand and forearm (Fig. 1a, b).
The initial differential diagnoses included subcutaneous
mycosis and malignant melanoma. Histopathological
examination showed ulceration and granulomatous le-
sions with multinucleated giant cells in the deep dermis.
A periodic acid-Schiff stain revealed no fungi in the spe-
cimen, but a tissue culture was positive for Alternaria, a
dematiaceous fungus. A diagnosis of dermal cutaneous
alternariosis was made. The patient was started on itra-
conazole therapy, but her nodules increased in size and
number within the next 2 months. Rebiopsy of a nodule
on the patient’s palm revealed the proliferation of atyp-
ical polygonal or oval epithelioid cells in the dermis and
lymphocyte infiltration through the dermis (Fig. 2).
Immunohistochemically, the tumor cells were positive
for vimentin, cell adhesion molecule 5.2 (CAM5.2), epi-
thelial membrane antigen (EMA), and E26-related gene
(ERG) (Fig. 3a–c); they were negative for AE1/AE3,
CD34, S100, smooth muscle actin, and CD31. The nu-
clear expression of integrase interactor 1 (INI1) was lost
in the tumor cells (Fig. 3d).
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On the basis of these findings, a diagnosis of ES was
made. Preoperative fluorodeoxyglucose-positron emis-
sion tomography showed elevated glucose levels in the
multiple lesions on the patient’s left hand, left forearm,
and left axillary lymph nodes (Fig. 4). After shoulder dis-
articulation and axillary lymph node dissection, there
was no recurrence, and no metastases were observed
during 9 months of follow-up.
Discussion
ES, a rare and highly malignant soft tissue tumor, shows
a high tendency for local recurrence, regional lymph
node involvement, and distant metastases [1]. ES consti-
tutes less than 1 % of all soft tissue sarcomas [2]. It is
characterized clinically by a firm and slow-growing
tumor with a predilection for the hands, fingers, and
forearms. Fifty-four percent of cases arise in the distal
upper extremities [2]. Pain or tenderness is rarely a
prominent symptom, unless large nerves are affected by
the tumor. ES is commonly seen in young patients; the
peak incidence is in the third decade of life, and it is rare
in children and the elderly.
Recurrence and metastasis are reported in 77 % and
45 % of patients with ES, respectively. The most com-
mon sites of metastasis are the lungs (51 %), regional
lymph nodes (34 %), scalp (22 %), and bone (13 %) [2].
ES is highly malignant; 32 % of patients die as a result
of the disease [3]. Male sex, proximal location, large
tumor size (greater than 50 mm), deep location, high
mitotic index, hemorrhage, necrosis, vascular invasion,
and inadequate initial excision causing local recurrence
have been shown to be poor prognostic factors [4].
Fig. 1 a A 2-cm ulcerated nodule on the left hand. b Multiple lesions on the patient’s left forearm
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Clinical features of the reported cases are summarized
in Table 1.
A new subtype, a proximal variant of ES, has been pro-
posed [5]. This subtype exhibits more aggressive clinical
behavior, and its histopathological appearance is distinct.
Clinically, the proximal subtype differs from the classical
type by its multinodular growth pattern, its more frequent
occurrence in older patients, its more proximal/axial dis-
tribution, its more deep-seated location, and its more ag-
gressive clinical behavior from the outset. Histologically, it
Fig. 2 Histopathological examination of a skin biopsy from a nodule on the palm. The lesion was composed of a proliferation of atypical
polygonal or oval epithelioid cells in the dermis with lymphocytic infiltration through the dermis. Hematoxylin and eosin stain, original
magnification ×200
Fig. 3 Immunohistochemical staining for (a) vimentin, (b) cell adhesion molecule 5.2, and (c) epithelial membrane antigen. (d) The nuclear
expression of integrase interactor 1 was diminished in the tumor cells
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is characterized by predominantly large cells, epithelioid
cytomorphology, marked cytological atypia, the frequent
manifestation of rhabdoid features, and the absence of a
granuloma-like pattern in most patients. On the basis of
our clinical and histological findings, we considered the
ES in our patient to be of the conventional distal type.
The cellular elements of ES range from large ovoid or
polygonal cells with deeply eosinophilic cytoplasm to
plump, spindle-shaped cells [3]. Consequently, ES is
often misdiagnosed as one of numerous benign and
malignant disorders, and proper treatment is delayed.
The median interval between the initial diagnosis and
the start of treatment is 3.5 months (range 1–6 months)
[6]. Nishimura et al. [7] reported a patient with ES
masquerading as an intractable wound for more than
18 years. We correctly diagnosed our patient 4 months
after her initial presentation.
Immunohistochemical examination is essential to
making a diagnosis of ES. Characteristically, it shows
expression of vimentin and low-molecular-weight cyto-
keratins such as those recognized by the monoclonal
antibody CAM5.2 [8, 9], and 85–96 % of cases are
EMA-positive [4]. The staining pattern suggests that ES
is a neoplasm of mesenchymal origin with epithelial de-
differentiation. Vimentin is rarely negative. CD34,
expressed in approximately 50 % of ES lesions, is used
as an additional diagnostic marker in vimentin-negative
cases. The INI1 gene is a member of the adenosine
triphosphate-dependent SWI/SWF chromatin-remodeling
complex and thus a candidate as a tumor suppressor gene.
Loss of the INI1 gene is seen in some patients with malig-
nant rhabdoid tumors; its loss is 93 % sensitive for a
diagnosis of ES [10].
ERG, a member of the erythroblast transformation-
specific family of transcription factors, is a marker of
endothelial differentiation [11]. Kohashi et al. [12], who
analyzed the expression of ERG in INI1-deficient tu-
mors, including ES, reported that ERG was expressed in
13 of 24 conventional distal type lesions and 5 of 20
patients with proximal-type ES. All of their patients with
Table 1 Clinical features of previously reported cases and our
patient
Reported cases [5] Our patient
Male sex, % 42–79 −
Female sex, % 21–62 +
Mean age at first symptoms,
years
23–41 74
Mean symptom duration before
diagnosis, months
7.1–36 4
Local recurrence, % 29–85 +
Lymph node metastases, % 11–65 +
Distant metastases, % 21–62.5 −
Fig. 4 Preoperative fluorodeoxyglucose-positron emission tomography
showed elevated glucose levels in the multiple lesions on the left hand,
left forearm, and left axillary lymph nodes
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malignant rhabdoid tumors had negative test results for
ERG, suggesting that ERG may be a useful marker to
distinguish ES from malignant rhabdoid tumors with
loss of INI1.
Cancer antigen 125 (CA-125) is a high-molecular-
weight glycoprotein commonly used for the identifica-
tion of epithelial ovarian carcinomas; it has also been
detected in various neoplasms, including carcinomas of
the breast, lung, and colon, and in patients with lymph-
oma. Kato et al. [13] documented that 10 (91 %) of 11
patients with ES had positive test results for CA-125;
10 manifested the classical type and the other had the
proximal type of the disease. In other soft tissue tu-
mors, including synovial sarcomas, clear cell sarcomas,
leiomyosarcomas, rhabdomyosarcomas, liposarcomas,
malignant peripheral nerve sheath tumors, malignant
fibrous histiocytomas, desmoid tumors, cutaneous
squamous cell carcinomas, and rheumatoid nodules,
CA-125 was negative. Other authors [8, 9] have sug-
gested that CA-125 immunoreactivity in the presence
of an elevated serum CA-125 level could be a useful
tumor marker for the diagnosis of ES and for monitor-
ing the clinical course of patients with ES.
Conclusions
ES is very rare and appears to be a benign lesion in the
early stage, and it is often misdiagnosed as a benign dis-
ease such as granuloma. We encountered a rare case of
ES and had difficulty in making the correct diagnosis.
We suggest that in patients whose lesions are resistant
to conventional treatments, repeat biopsy and immuno-
histochemical studies should be considered to rule out
rare ES.
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